| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |